DORIS TATE: Open Payments
NPI 1275975542 · ST MICHAELS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$390 in 10 payments from 5 companies in 2025. Trend: 2023 $16,311 · 2024 $4,330 · 2025 $390
Food & beverage: $390
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 4 | $163 |
| Galderma Laboratories, L.P. | 2 | $141 |
| REVANCE THERAPEUTICS, INC. | 2 | $47 |
| BETA BIONICS, INC. | 1 | $22 |
| Novo Nordisk Inc | 1 | $16 |
Products named: DEXCOM G7 GSS (161), Dexcom G6 Transmitter, DAXXIFY, iLet Bionic Pancreas, DYSPORT.
Industry payments across MD — which companies pay providers there.
